Serum Potassium Trajectory During AKI and Mortality Risk
| dc.contributor.author | Jonathan S. Chávez-Íñiguez | |
| dc.contributor.author | Pablo Maggiani‐Aguilera | |
| dc.contributor.author | Andrés Aranda-García de Quevedo | |
| dc.contributor.author | Rolando Claure‐Del Granado | |
| dc.contributor.author | Olynka Vega‐Vega | |
| dc.contributor.author | Salvador López-Giacoman | |
| dc.contributor.author | Gael Chávez-Alonso | |
| dc.contributor.author | Ana E. Oliva-Martínez | |
| dc.contributor.author | Bladimir Díaz-Villavicencio | |
| dc.contributor.author | Clementina E. Calderón-García | |
| dc.coverage.spatial | Bolivia | |
| dc.date.accessioned | 2026-03-22T20:46:58Z | |
| dc.date.available | 2026-03-22T20:46:58Z | |
| dc.date.issued | 2022 | |
| dc.description.abstract | Abstract Background: Kidneys play a primary role in potassium homeostasis. The association between potassium (sK + ) level and mortality or the need for kidney replacement therapy (KRT) during acute kidney injury (AKI) has not been adequately explored. Methods: In this prospective cohort study, AKI patients admitted to the Hospital Civil de Guadalajara were enrolled from August 2017 to June 2021 with AKI. We divided patients into 8 groups based on the serum potassium level trajectories up to ten days following hospitalization, (1) normokalemia (normoK), defined as sK + values between 3.5 and 5.5 mEq/L; (2) corrected hyperkalemia (hyperK), sK + > 5.5 mEq/L on hospital admission and decreased to normoK; (3) corrected hypokalemia (hypoK), sK + < 3.5 mEq/L on hospital admission and increased to normoK; (4) fluctuating potassium, sK + increased / decreased in and out of normoK parameters; (5) uncorrected hypoK, sK + < 3.5 mEq/L; (6) normoK to hypoK, sK + that were normal on hospital admission and decreased to hypoK and never went back to normal; (7) normoK to hyperK, sK + that were normal on hospital admission and increased to hyperK and never went back to normal; (8) uncorrected hyperK, sK + > 5.5 mEq/L. We assessed the association of serum potassium trajectories with mortality and the need for KRT (secondary objective). Results: A total of 311 AKI patients were included. The mean age was 52.6 years, and 182 (58.6%) were male. AKI stage 3 was present in 199 (63.9%). KRT started in 112 (36%) patients, and 66 (21.2%) died. After adjusting for confounders, 10-day hospital mortality was significantly higher in group 7 and 8 (OR, 1.37 and 1.63, p = <0.05, for both, respectevely), and KRT initiation was higher only in group 8 (OR 1.40, p = < 0.05) compared with group 1. Mortality in different subgroups of patients in group 8 did not change the primary results. Conclusion: In our prospective cohort, most patients with AKI had alterations in sK + . NormoK to hyperK and Uncorrected hyperK were associated with death, while only uncorrected hyperK was correlated with the need for KRT. | |
| dc.identifier.doi | 10.21203/rs.3.rs-1285007/v2 | |
| dc.identifier.uri | https://doi.org/10.21203/rs.3.rs-1285007/v2 | |
| dc.identifier.uri | https://andeanlibrary.org/handle/123456789/84038 | |
| dc.language.iso | en | |
| dc.publisher | Research Square (United States) | |
| dc.relation.ispartof | Research Square (Research Square) | |
| dc.source | Universidad de Guadalajara | |
| dc.subject | Hyperkalemia | |
| dc.subject | Hypokalemia | |
| dc.subject | Medicine | |
| dc.subject | Acute kidney injury | |
| dc.subject | Potassium | |
| dc.subject | Internal medicine | |
| dc.subject | Prospective cohort study | |
| dc.subject | Gastroenterology | |
| dc.title | Serum Potassium Trajectory During AKI and Mortality Risk | |
| dc.type | preprint |